Intralacrimal migration of Masterka <sup>®</sup> stents. En savoir plus sur Intralacrimal migration of Masterka ® stents.
Severe Inflammatory Ophthalmopathy in a Euthyroid Patient during Nivolumab Treatment. En savoir plus sur Severe Inflammatory Ophthalmopathy in a Euthyroid Patient during Nivolumab Treatment.
Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts. En savoir plus sur Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts.
Comparative study of 0.1% hyaluronic acid versus 0.5% carboxymethylcellulose in patients with dry eye associated with moderate keratitis or keratoconjunctivitis. En savoir plus sur Comparative study of 0.1% hyaluronic acid versus 0.5% carboxymethylcellulose in patients with dry eye associated with moderate keratitis or keratoconjunctivitis.
Accuracy of peripapillary versus macular vessel density in diagnosis of early to advanced primary open angle glaucoma. En savoir plus sur Accuracy of peripapillary versus macular vessel density in diagnosis of early to advanced primary open angle glaucoma.
DIABSAT Telemedicine Itinerant Screening of Chronic Complications of Diabetes Using a Satellite. En savoir plus sur DIABSAT Telemedicine Itinerant Screening of Chronic Complications of Diabetes Using a Satellite.
[Regression of myelinated retinal nerve fibers in a case of primary open-angle glaucoma]. En savoir plus sur [Regression of myelinated retinal nerve fibers in a case of primary open-angle glaucoma].
[Ocular hypertension after intravitreal injection: Screening and management]. En savoir plus sur [Ocular hypertension after intravitreal injection: Screening and management].
[Treatment of macular edema: Comparison of efficacy and tolerability of subconjunctival triamcinolone injections, sub-tenon''s triamcinolone injections and intravitreal dexamethasone implant]. En savoir plus sur [Treatment of macular edema: Comparison of efficacy and tolerability of subconjunctival triamcinolone injections, sub-tenon''s triamcinolone injections and intravitreal dexamethasone implant].
Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis. En savoir plus sur Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis.
